These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27907860)

  • 1. Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancer.
    Heger Z; Polanska H; Krizkova S; Balvan J; Raudenska M; Dostalova S; Moulick A; Masarik M; Adam V
    Colloids Surf B Biointerfaces; 2017 Feb; 150():131-140. PubMed ID: 27907860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
    Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
    Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of chitosan polyethylene glycol antibody complex for delivery of Imatinib in lung cancer cell lines.
    Kamali M; Jafari H; Taati F; Mohammadnejad J; Daemi A
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23787. PubMed ID: 39072816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines.
    Zangemeister-Wittke U; Schenker T; Luedke GH; Stahel RA
    Br J Cancer; 1998 Oct; 78(8):1035-42. PubMed ID: 9792147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.
    Song L; Coppola D; Livingston S; Cress D; Haura EB
    Cancer Biol Ther; 2005 Mar; 4(3):267-76. PubMed ID: 15753661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.
    Khodadadian M; Leroux ME; Auzenne E; Ghosh SC; Farquhar D; Evans R; Spohn W; Zou Y; Klostergaard J
    Lung Cancer; 2009 Oct; 66(1):48-57. PubMed ID: 19195736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
    Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
    Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
    Tahir SK; Yang X; Anderson MG; Morgan-Lappe SE; Sarthy AV; Chen J; Warner RB; Ng SC; Fesik SW; Elmore SW; Rosenberg SH; Tse C
    Cancer Res; 2007 Feb; 67(3):1176-83. PubMed ID: 17283153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo.
    Jiang H; Zhao PJ; Su D; Feng J; Ma SL
    Mol Med Rep; 2014 Jun; 9(6):2265-72. PubMed ID: 24718383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.
    Zangemeister-Wittke U; Leech SH; Olie RA; Simões-Wüst AP; Gautschi O; Luedke GH; Natt F; Häner R; Martin P; Hall J; Nalin CM; Stahel RA
    Clin Cancer Res; 2000 Jun; 6(6):2547-55. PubMed ID: 10873111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous evaluation of viability and Bcl-2 in small-cell lung cancer.
    Santos A; Sarmento-Ribeiro AB; de Lima MC; Simões S; Moreira JN
    Cytometry A; 2008 Dec; 73A(12):1165-72. PubMed ID: 18785266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancer" [Colloids Surf. B Biointerfaces 150 (2017) 131-140].
    Heger Z; Polanska H; Krizkova S; Balvan J; Raudenska M; Dostalova S; Moulick A; Masarik M; Adam V
    Colloids Surf B Biointerfaces; 2022 Apr; 212():112361. PubMed ID: 35131713
    [No Abstract]   [Full Text] [Related]  

  • 14. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher spontaneous apoptotic index in small cell compared with non-small cell lung carcinoma cell lines; lack of correlation with Bcl-2/Bax.
    Sirzén F; Zhivotovsky B; Nilsson A; Bergh J; Lewensohn R
    Lung Cancer; 1998 Oct; 22(1):1-13. PubMed ID: 9869102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG-coumarin nanoaggregates as π-π stacking derived small molecule lipophile containing self-assemblies for anti-tumour drug delivery.
    Behl G; Kumar P; Sikka M; Fitzhenry L; Chhikara A
    J Biomater Sci Polym Ed; 2018 Mar; 29(4):360-375. PubMed ID: 29271302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RB protein status and chemosensitivity in non-small cell lung cancers.
    Yamamoto Y; Shimizu E; Masuda N; Takada M; Sone S
    Oncol Rep; 1998; 5(2):447-51. PubMed ID: 9468577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
    Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
    Rudin CM; Kozloff M; Hoffman PC; Edelman MJ; Karnauskas R; Tomek R; Szeto L; Vokes EE
    J Clin Oncol; 2004 Mar; 22(6):1110-7. PubMed ID: 15020613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.